Request Demo
Last update 05 Jul 2025
VEGF (NIH)
Last update 05 Jul 2025
Overview
Basic Info
Drug Type Biological products |
Synonyms VEGF (NIH) |
Target |
Action agonists |
Mechanism VEGFR agonists(Vascular endothelial growth factor receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Peripheral Vascular Diseases | Clinical | United States | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 23 | Patients treated with sirolimus | faehuraxbo(lukniiznrq) = mdqoksktog eukykikstr (msbvsgokdf ) | - | 28 Sep 2019 | ||
Not Applicable | Retinal Diseases vascular endothelial growth factor (VEGF) | - | VEGF (PDR) | fczlrcjrsp(rdwkofcqrg) = ioiojibmsu zruntdlsxj (ejzedfyeak ) | - | 01 Jul 2019 | |
VEGF (CRVO) | fczlrcjrsp(rdwkofcqrg) = pdjtadnmqv zruntdlsxj (ejzedfyeak ) | ||||||
Not Applicable | Retinal Diseases VEGF | - | VEGF (Ischemic preconditioning) | mgjbodlmwb(yrtmsxmvot) = vqgtktwjzv zrcimtvkwi (xvnwlpdqzz ) | - | 01 May 2004 | |
Not Applicable | Retinal Vein Occlusion vascular endothelial growth factor (VEGF) | 7 | VEGF (Branch Retinal Vein Occlusion (BRVO)) | kazgnhjahz(mvlpsxxmqx) = feectqjkee ttylwaabra (ewctiawvmc, 0 - 552) View more | - | 01 May 2004 | |
VEGF (Hemi-Retinal Vein Occlusion (HRVO)) | rakdotfsqg(xszpvmvcax) = gittalvdtf voabuedsrf (xrbvufiest ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free